Ascorbate depletion as a consequence of product recycling during dopamine beta-monooxygenase catalyzed selenoxidation.
The competence of dopamine beta-monooxygenase (DBM) to process selenide substrates was investigated, in anticipation that the expected selenoxide products would exhibit unique reactivity and redox properties. The prototypical selenide phenyl 2-aminoethyl selenide (PAESe) was synthesized and shown to be a substrate for DBM with the characteristic e/O2 ratio of 2:1 for monooxygenation. The kinetic parameters for oxygenation of PAESe were found to be similar to those for the DBM-catalyzed sulfoxidation of the cognate sulfide phenyl 2-aminoethyl sulfide [May, S. W., & Phillips, R. S. (1980) J. Am. Chem. Soc. 102, 5981-5983], and selenoxidation was stimulated by fumarate in a manner similar to other well-characterized DBM monooxygenation reactions. Identification of phenyl 2-aminoethyl selenoxide (PAESeO) as the enzymatic product was accomplished by the demonstration of coincident elution of authentic PAESeO with the enzymatic product in three significantly different HPLC systems. PAESeO was found to oxidize ascorbic acid with the concomitant and stoichiometric reduction of PAESeO back to the selenide, PAESe. As a consequence of this nonenzymatic reaction, ascorbate-supported DBM turnover was prematurely terminated under standard assay conditions due to depletion of reduced ascorbate. The kinetics of the redox reaction between PAESeO and ascorbate were investigated with a spectrophotometric assay of ascorbate at 300 nm, and a second-order rate constant of 3.4 M-1 s-1 was determined at pH 5.0, 25 degrees C. Spectrophotometric assay of cytochrome c (cyt c) reduction at 550 nm during the oxidation of ascorbate by PAESeO demonstrated that no cyt c trappable semidehydroascorbate was produced in this nonenzymatic reaction.(ABSTRACT TRUNCATED AT 250 WORDS)
D000311:Adrenal Glands / Q000201:enzymology; D000818:Animals; D001205:Ascorbic Acid / Q000378:metabolism*; D002417:Cattle; D003574:Cytochrome c Group / Q000378:metabolism; D004299:Dopamine beta-Hydroxylase / Q000378:metabolism*; D007202:Indicators and Reagents; D007700:Kinetics; D016566:Organoselenium Compounds; D010084:Oxidation-Reduction; D010087:Oxides / Q000138:chemical synthesis / Q000378:metabolism*; D010627:Phenethylamines / Q000138:chemical synthesis / Q000378:metabolism*; D012643:Selenium / Q000378:metabolism*
D003574:Cytochrome c Group; D007202:Indicators and Reagents; D016566:Organoselenium Compounds; D010087:Oxides; D010627:Phenethylamines; C052743:phenyl 2-aminoethyl selenoxide; D004299:Dopamine beta-Hydroxylase; D012643:Selenium; D001205:Ascorbic Acid